Growth Of The Yellow Fever Vaccine Market Due To Increasing International Travel: Transformative Forces Shaping the Yellow Fever Vaccine Market Landscape in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Yellow Fever Vaccine Industry Market Size Be by 2025?
The market size of the Yellow Fever vaccine has been expanding gradually in the past few years. It is projected to increase from $4.54 billion in 2024 to $4.74 billion in 2025, with a compound annual growth rate (CAGR) of 4.4%. The expansion during this historic period can be traced back to the commencement of worldwide immunization initiatives, the application of international health guidelines, extensive vaccination programs, and progress in vaccine manufacturing technology.

What's the Long-Term Growth Forecast for the Yellow Fever Vaccine Market Size Through 2029?
In the coming years, the market for yellow fever vaccine is projected to undergo consistent expansion, reaching a value of "$5.66 billion by 2029 with a 4.5% compound annual growth rate (CAGR). The predicted growth during the forecast period is due to factors such as heightened collaboration and partnerships, inclusion in routine immunization schedules, vigilant surveillance and tracking, rising involvement from private entities, and the adoption of digital solutions for vaccination records. Key trends to watch for during this period are the diversification of vaccine formats, readiness for pandemics, regulatory adjustments, enhancements in healthcare infrastructure, and the promotion of consumer knowledge and consciousness about their health.

View the full report here:
https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

What Are the Key Growth Drivers Fueling the Yellow Fever Vaccine Market Expansion?
The surge in international travel is anticipated to fuel the expansion of the yellow fever vaccine market. The term "international travel" refers to the crossing of national borders by people for a variety of reasons, including tourism, business, or personal reasons. Global connectivity, economic development, and the easing of travel restrictions following the pandemic have all contributed to the rise in international travel. Vaccination against yellow fever is either mandatory or suggested for individuals traveling to areas where the disease is prevalent to avoid infection and meet international health regulations. As reported by the World Tourism Organization, a Spain-based entity, the number of international overnight tourists stood at 1.286 billion in 2023, a significant jump from the 960 million recorded in 2022, indicating an increase of 326 million international tourists. Hence, the escalating international travel trend is propelling the yellow fever vaccine market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp

What Are the Key Trends Driving Yellow Fever Vaccine Market Growth?
Key players in the yellow fever vaccine market are concentrating their efforts on creating efficient, next-generation vaccines for yellow fever, such as the T-cell adaptive booster vaccine, to satisfy the rising global need for vaccines. A T-cell adaptive booster vaccine aims to strengthen the immune system's memory T-cell response, offering lasting and potent defense against certain diseases. In April 2022, for example, Emergex Vaccines Holding Limited, a biotechnology firm based in the UK, teamed up with ATCC, a US-based non-profit organization that provides reference microorganisms and cell lines for research and development. Their aim is to launch CD8+ T-cell adaptive vaccines, tailored specifically for yellow fever. These vaccines are designed to stimulate a strong cytotoxic T-cell response crucial for detecting and eliminating cells infected by the virus. With their focus on generating memory CD8+ T-cells, these vaccines offer durable and potent immunity. Unlike traditional vaccines that only focus on antibody production, these next-gen vaccines offer complete protection against yellow fever and could potentially be more effective for individuals with varied immune profiles.

How Is the Yellow Fever Vaccine Market Segmented?
The yellow fever vaccine market covered in this report is segmented -

1) By Product: Powder, Liquid
2) By Treatment Type: Pain Management Drugs, Oral Rehydration
3) By Application: Routine Immunization, Travelers, Other Applications
4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:
1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution
2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=17297&type=smp

Which Companies Are Leading the Charge in Yellow Fever Vaccine Market Innovation?
Major companies operating in the yellow fever vaccine market are Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.

Which Regions Are Leading the Global Yellow Fever Vaccine Market in Revenue?
North America was the largest region in the yellow fever vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17297

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Reach Out to Us
Speak With Our Expert:Saumya Sahay,
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267,
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.